Oxford Medical Simulation (OMS), a UK startup offering clinical simulation to healthcare and academic institutions, has secured €5.78 million (£5 million) in growth funding from Salica Investments, a UK-based investment firm supporting high-growth companies across the UK and Europe.
The funding will allow OMS to expand its presence in US health systems and academic institutions, invest in product innovation such as AI-driven scenarios, learning analytics, and workflow tools, and enhance the infrastructure required to provide safer, more effective clinical training.
“This financing allows us to invest confidently in the next phase of OMS. Our partners in US healthcare and academia are focused on outcomes – safer practice, better-prepared staff and more efficient delivery. This growth capital from Salica means we can move faster on exactly those priorities: expanding our breadth and depth of content, deepening our analytics capabilities, and supporting more institutions to transform their training for the new generation of learners,” said Michael Wallace, CEO of Oxford Medical Simulation.
Founded in 2017 by Michael Wallace and Dr Jack Pottle, Oxford Medical Simulation (OMS) designs, builds, and delivers virtual reality healthcare training. It collaborates with hospitals, health systems, and universities worldwide to offer realistic AI-driven simulations for clinicians and students to practice anytime, anywhere.
Using VR headsets, learners can engage in fully interactive clinical scenarios that simulate real life. They then receive personalised feedback and can repeat the scenarios as often as they wish to enhance their skills.
In 2024, Oxford Medical Simulation (OMS) announced the completion of its €10.9 million ($12.6 million) Series A funding round, led by Frog Capital. In 2022, the company raised about €2.4 million in additional funding with support from ACF Investors.
“Oxford Medical Simulation is exactly the type of business we look to support. The team has built a differentiated platform, proven at scale, and is working with leading health systems and universities to address a critical need: giving clinicians and students the chance to practise safely,” said Usman Ali, Partner at one of the funds at Salica.
Salica was originally founded as an investment firm specialising in the most promising businesses. It has since developed into a diverse set of private market funds investing in equity and debt across various sectors and stages, primarily within the UK. Last year, in October, the investment firm announced the first close of its €173.5 million (£150 million) Growth Debt Fund II
Read the orginal article: https://www.eu-startups.com/2026/03/oxford-medical-simulation-secures-e5-78-million-to-tackle-healthcare-training-gap-with-virtual-reality/
